Alpha-interferon prevents liver collagen deposition and damage induced by prolonged bile duct obstruction in the rat

Journal of Hepatology

Volumn 24, Issue 5, 1996, Pages 614-621

  Muriel, Pablo ^a  

^a DEPARTAMENTO DE FÍSICA   (Mexico)

Author keywords

Antifibrotic drugs; Biliary obstruction; Cholestasis; Collagen; Fibrosis; Interferons; Liver damage

Indexed keywords

ALPHA INTERFERON; ALPHA2B INTERFERON; RECOMBINANT ALPHA2B INTERFERON;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BILE DUCT OBSTRUCTION; CHOLESTASIS; COLLAGEN SYNTHESIS; CONTROLLED STUDY; ELECTRON MICROSCOPY; FIBROGENESIS; HISTOLOGY; HUMAN; LIVER FIBROSIS; LIVER INJURY; MALE; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0030005370     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(96)80148-6     Document Type: Article

References (46)

1. Duncan MR, Berman B. Gamma-interferon is the lymphokine and β-interferon the monokine responsible for inhibition of fibroblast collagen production and late but not early fibroblast proliferation. J Exp Med 1985; 162: 516-27.
2. Jiménez SA, Freundlich B, Rosenbloom T. Selective inhibition of human diploid fibroblast collagen synthesis by interferons. J Clin Invest 1984; 74: 1112-6.
3. Stephenson ML, Krane SM, Amento EP, McCroskery PA, Byrne M. Immune interferon inhibits collagen synthesis by rheumatoid synovial cells associated with decreased levels of procollagen mRNAs. FEBS Lett 1985; 180: 43-50.
4. Goldring MB, Sandell LJ, Stephenson ML, Krane SM. Immune interferon suppresses levels of procollagen mRNA and type II collagen synthesis in cultured human auricular and costal chondrocytes. J Biol Chem 1986; 261: 9049-56
5. Granstein RD, Murphey GF, Margolis RJ. Gamma-interferon inhibits collagen synthesis in vivo in the mouse. J Clin Invest 1987; 79: 1254-58.
6. Czaja MJ, Weiner FR, Takahashi S, Giambrone MA, Van Der Meide PH, Schellekens H, Biempica L, et al. Gamma-interferon treatment inhibits collagen deposition in urine schistosomiasis. Hepatology 1989; 10: 795-800.
7. Kountaras J, Barbara H, Billing JS, Billing P. Prolonged bile duct obstruction: a new experimental model for cirrhosis in the rat. Br J Exp Path 1984; 65: 305-11.
8. Carpino F, Gaudio E, Marinozzi G, Melis M, Motta PM. A scanning and transmission electron microscopic study of experimental extrahepatic cholestasis in the rat. J Submicrosc Cytol 1981; 13: 581-59.
9. Muriel P, Suárez OR, González P, Zúñiga L. Protective effect of S-adenosyl-L-methionine on liver damage induced by biliary obstruction in rats. A histological, ultrastructural and biochemical approach. J Hepatol 1994; 21: 95-102.
10. 14C in collagen and in non collagenous proteins. Anal Biochem 1974; 57: 1-7.
11. Bergmeyer HU, Grabl M, Walter HE. Enzymes. In: Bergmeyer J, Grabl M, eds. Methods of Enzymatic Analysis. Weinheim: Verlagchemie, 1983; 269-70.
12. Glossmann M, Neville DM. Glutamyl transferase in kidney brush border membranes. FEBS Lett 1972; 19: 340-4.
13. Seifter S, Seymour B, Novic B, Muntwyler E. The estimation of glycogen with the anthrone reagent. Arch Biochem 1950; 25: 191-200.
14. Ohkawa H, Ohnishi N, Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 1979; 95: 351-8.
15. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976; 72: 248-54.
16. Zar JH. Biostatistical Analysis. New Jersey: Prentice-Hall, 1984.
17. Muriel P, Bolaños J, Barral JM, Torres G, Effect of alpha-interferon on erythrocyte and hepatocyte plasma membranes derived from cirrhotic rats. Pharmacology 1994; 48: 63-8.
18. Popper H, Kent G. Fibrosis in chronic liver diseases. Clin Gastroenterol 1975; 4: 315.
19. Williams R, Smith P, Spicer E, Barry M, Sherlock S. Venesection therapy in idiopathic haemochromatosis. Q J Med 1969; 38: 1-16.
20. Bunton GL, Cameron GR. Regeneration of liver after biliary cirrhosis. Ann N Y Acad Sci 1963; 111: 412-21.
21. Yeong ML, Nicholson GI, Lee SP. Regression of biliary cirrhosis following choledochal cyst drainage. Gastroenterology 1982; 82: 332-5.
22. Abdel-Aziz G, Leveau G, Rescan PY, Clément B, Sieel M, Deugnier Y, Campion JP, Guillouzo A. Reversibility of hepatic fibrosis in experimentally induced cholestasis in the rat. Am J Pathol 1990; 137: 1333-42.
23. 4 and biliary obstruction-induced liver damage in the rat. Life Sci 1993; 52: 647-55.
24. Aronson DC, Chamuleau RAFM, Frederiks WM, Gooszen HG, Heijmans HSA, James J. Reversibility of cholestatic changes following experimental common bile duct obstruction: fact or fantasy? J Hepatol 1993; 18: 85-95.
25. Cameron GR, Hasan SM. Disturbances of structure and function in the liver as the result of biliary obstruction. J Pathol Bacteriol 1958; 75: 333-49.
26. Davis GL, Balart La, Schiff ER, Lindsay K, Bodenheimer HC, Perrillo RP, Carey W, Jacobson IM, Payne J, Dienstag JL, Van Thiel DH, Tamburro C, Lefkowitch J, Albrecht J, Meschievitz C, Ortego TJ, Gibas A, The Hepatitis Interventional Therapy Group. Treatment of chronic hepatitis C with recombinant interferon alpha: a multicenter randomized, controlled trial. N Engl J Med 1989; 321: 1501-6.
27. Di Bisceglie AM, Martin P, Kassianides C, Lisker-Melman M, Murray L, Waggoner J, Goodman Z, Banks SM, Hoofnagle JH. Recombinant interferon alpha therapy for chronic hepatitis C: a randomized, double-blind, placebo-controlled trial. N Engl J Med 1989; 321: 1506-10.
28. Israel BC, Blouin RA, McIntaire W, Shedlofsky SI. Effects of interferon-gamma monotherapy on hepatic drug metabolism in cancer patients. Br J Clin Pharmacol 1993; 36: 229-235.
29. Proctor E, Chatamra K. High-yield micronodular cirrhosis in the rat. Gastroenterology 1982; 83: 1183-1190.
30. 4 an adequate model of human cirrhosis? Hepatology 1983; 3: 112-120.
31. Muriel P, Suárez OR. Role of lipid peroxidation on biliary obstruction in the rat. J Appl Toxicol 1994; 14: 423-6.
32. Omata M, Ito Y, Yosuka O, Imazeki F, Uchiumi K, Takano S, Hosoda K, Ohto M. Histological changes in chronic hepatitis B. Dig Dis Sci 1989; 34 330-337.
33. Hoofnagle JH, Kevin KD, Jones DB, Rustgi V, Di Bisceglie, Peters M, Waggoner JG, Park Y, Jones EA. Treatment of chronic non-A, non-B hepatitis with recombinant human alpha interferon. A preliminary report. N Engl J Med 1986; 315: 1575-8.
34. Castilla A, Prieto J, Fausto N. Transforming growth factors β1 and α in chronic liver disease. Effects of interferon alpha therapy. N Engl J Med 1991; 324: 933-40.
35. Davis GL, Balart LA, Schiff ER, Lindsay K, Bodenheimer HC, Perrillo RP, Carey W, Jacobson IM, Payne J, Dienstag JL, Van Thiel DH, Tamburro C, Lefkowitch J, Albrecht J, Meschievitz C, Ortego TJ, Gibas A, The Hepatitis Interventional Therapy Group. Treatment of chronic hepatitis C with recombinant interferon alpha: a multicenter randomized, controlled trial. N Engl J Med 1989; 321: 1501-6.
36. Di Bisceglie Am, Martin P, Kassianides C, Lisker-Melman M, Murray L, Waggoner J, Goodman Z, Banks SM, Hoofnagle JH. Recombinant interferon alpha therapy for chronic hepatitis C: a randomized, double-blind, placebo-controlled trial. N Engl J Med 1989; 321: 1506-10.
37. Kershenobich D, Vargas F, García-Tsao G, Pérez-Tamayo R, Gent M, Rojkind M. Colchicine in the treatment of cirrhosis of the liver. N Engl J med 1988; 318: 1709-13.
38. Kovacs EJ. Fibrogenic cytokines: the role of immune mediators in the development of scar tissue. Immunol Today 1991; 12: 17-22.
39. 2b therapy reduces liver fibrosis in chronic non-A, non-B hepatitis: a quantitative histological evaluation. Hepatology 1993; 18: 1344-9.
40. Capra F, Casaril M, Gabrielli NG, Tognella P, Rizzi A, Dolci L, Colombardi R. α-interferon in the treatment of chronic viral hepatitis: effects on fibrogenesis serum markers. J Hepatol 1993; 18: 112-8.
41. Rockey DC, Boyles JK, Gabbiani G, Friedman SL. Rat hepatic lipocytes express smooth muscle actin upon activation in vivo and in culture. J Submicrosc Cytol Pathol 1992; 24: 193-203.
42. Kent G, Gay S, Inouve T, Bahu R, Minick OT, Popper H. Vitamin A-containing lipocytes and formation of type III collagen in liver injury. Proc Natl Acad Sci USA 1976; 73: 3719-22.
43. Enzan H. Proliferation of Ito cells (fat-storing cells) in acute carbon tetrachloride liver injury: a light and electron microscopic autoradiographic study. Acta Pathol Jpn 1985; 35: 1301-08.
44. Tanaka Y, Mak KM, Lieber CS. Immunohistochemical detection of proliferating lipocytes in regenerating rat liver. J Pathold 1990; 160: 129-34.
45. Rockey DC, Maher JJ, Jamagin WR, Gabbiani G, Friedman SL. Inhibition of rat hepatic lipocyte activation in culture by interferon-γ. Hepatology 1992; 16: 776-84.
46. Aycock RS, Seyer JM. Collagens of normal and cirrhotic human liver. Connect Tiss Res 1989; 23: 19-31.